IKang Healthcare : Termination of registration under Section 12(g) or suspension of duty to file reports

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES

EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 001-36403

IKANG HEALTHCARE GROUP, INC.

(Exact name of registrant as specified in its charter)

B-6F, Shimao Tower

92A Jianguo Road Chaoyang District, Beijing 100022

People's Republic of China

Tel: [phone]

(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

Class A Common Shares, par value US$0.01 per share

American Depositary Shares, each representing 1/2 Class A Common Shares

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)

x

Rule 12g-4(a)(2)

Rule 12h-3(b)(1)(i)

o x

Rule 12h-3(b)(1)(ii)

o

Rule 15d-6

o

Rule 15d-22(b)

o

Approximate number of holders of record as of the certification or notice date: one

Pursuant to the requirements of the Securities Exchange Act of 1934, iKang Healthcare Group, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Date:

January 31, 2019

iKang Healthcare Group, Inc.

By:	/s/ Lee Ligang Zhang
Name:	Lee Ligang Zhang
Title:	Chief Executive Officer